Sunday, October 16, 2016

Boots Nirolex Chesty Cough Relief Linctus





1. Name Of The Medicinal Product



Boots Nirolex Chesty Cough Relief Linctus


2. Qualitative And Quantitative Composition








Active ingredient




mg/5ml




Guaifenesin Ph Eur




100



3. Pharmaceutical Form



Oral solution



4. Clinical Particulars



4.1 Therapeutic Indications



An expectorant for the relief of chesty coughs.



For oral administration



4.2 Posology And Method Of Administration



Adults and children over 12 years:



Two 5ml spoonfuls every four hours up to four times a day.



Children under 12 years:



Not recommended.



Elderly:



There is no need for dosage reduction in the elderly.



4.3 Contraindications



Hypersensitivity to any of the ingredients.



4.4 Special Warnings And Precautions For Use



Not recommended for children under 12 years.



Keep all medicines out of the reach of children.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



There are no clinically significant interactions.



4.6 Pregnancy And Lactation



The safety of this product during pregnancy and lactation has not been established. However guaiphenesin is not considered to constitute a hazard during pregnancy since there is no evidence of an association with foetal malformations. There is no data available on use of guaiphenesin during breast feeding.



4.7 Effects On Ability To Drive And Use Machines



No adverse effects known.



4.8 Undesirable Effects



The following side effects may be associated with the use of guaifenesin:



Gastrointestinal disorders: nausea, vomiting/gastrointestinal discomfort.



Immune system disorder: hypersensitivity reactions, including anaphylaxis.



4.9 Overdose



Overdosage may give rise to nausea and vomiting.



Treatment need only be symptomatic and supportive.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Guaifenesin reduces the viscosity of tenacious sputum and is used as an expectorant.



5.2 Pharmacokinetic Properties



Guaifenesin is readily absorbed from the gastrointestinal tract. It is metabolised and excreted in the urine.



5.3 Preclinical Safety Data



Not applicable.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Liquid sugar demin



Hydroxyethylcellulose



Glycerin



Flav F menthol E43525



Potassium sorbate



Acesulfame K



Citric acid monohydrate



Sodium citrate



Food flavour 511630E TM



Blackcurrant 17407107



Purified water



6.2 Incompatibilities



None stated



6.3 Shelf Life



24 months



6.4 Special Precautions For Storage



Do not store above 25°C.



Do not refrigerate or freeze



6.5 Nature And Contents Of Container



An amber PET bottle with a polypropylene child resistant cap fitted with an expanded polyethylene liner.



Pack size: 150ml, 240ml, 300ml



6.6 Special Precautions For Disposal And Other Handling



Not applicable.



7. Marketing Authorisation Holder



The Boots Company PLC



1 Thane Road West



Nottingham NG2 3AA



8. Marketing Authorisation Number(S)



PL 00014/0554



9. Date Of First Authorisation/Renewal Of The Authorisation



21 April 1997



10. Date Of Revision Of The Text



May 2010





No comments:

Post a Comment